Mercer, a consulting firm, recently published the results of their new survey. Employers with at least 500 employees were surveyed and according to the results, 51% said they plan to increase cost-sharing in 2026, including raising deductibles and maximum out-of-pocket costs for workers. That percentage increased from 45% in 2025. 77% of employers named the cost of GLP-1 weight loss drugs as their top concern. According to the survey, employers are seeking out alternatives to the traditional, large pharmacy benefit managers (PBMs). Regulatory pressure and calls for transparency are generating interest in new models and smaller mid-market PBMs that offer flexibility, transparency, and innovative approaches to managing drug spend.
Contact ProAct today to learn how we can support the needs of employer groups looking for greater transparency, more control, and flexibility in coverage options.
